Welcome to our dedicated page for Merus N.V. SEC filings (Ticker: MRUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Merus N.V.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Merus N.V.'s regulatory disclosures and financial reporting.
Peter B. Silverman, COO & General Counsel of Merus N.V. (MRUS), executed a planned transaction under Rule 10b5-1 on June 20, 2025. The transaction involved:
- Exercise of 34,000 stock options at $18.61 per share
- Immediate sale of all 34,000 shares at a weighted average price of $52.76 (range: $52.44-$53.06)
- Retained 23,500 unexercised options from original February 14, 2020 grant
This transaction was conducted according to a pre-established Rule 10b5-1 trading plan adopted on March 20, 2025. The exercised options were fully vested, with an original expiration date of February 14, 2030. The sale represents a significant realization of gains, with approximately $1.16 million in gross proceeds before accounting for the exercise cost of $632,740.